Experience

IAG, IMAGE ANALYSIS GROUP

• United Kingdom
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Research And Development Engineer

  • Jan 2018 - Present

  I am a part of software development team at IAG, Image Analysis Group. We are a fast-growing medical imaging and technology company serving biotech and pharmaceutical clients. IAG provides expert and operational support when a bio-pharma company sets to develop and to test a novel drug using medical imaging-based markers. IAG brings novel approaches from the field of radiology and computer science to accelerate clinical trials. We develop and deploy the industry leading and most trusted platform DYNAMIKA, which supports imaging data collection and incorporates rich libraries of image analysis approaches.Our goal is to accelerate novel drug development by using the right analytical tools and modern trial infrastructure. Learn more: www.ia-grp.com



University College London Hospitals NHS Foundation Trust

• United Kingdom
• Hospitals and Health Care
• 700 & Above Employee

• Research Associate

  • Jan 2017 - Dec 2017

  Project: Brain atrophy measured from structural MRI has been widely used as an imaging biomarker for diagnosis and prognosis of neuro-degenerative diseases-notably Alzheimer Disease and dementia. The project includes nuclear imaging and requires the quantification of protein load in the brain as well as it changes over time. As a research associate, I have developed a medical image processing pipelines to extract and analyse imaging biomarker from structural and functional MRI scans. These imaging biomarkers are targeting the quantification of regional atrophy, white matter damage and cortical grey matter thickness. I was also involved in developing a robust tensor-based morphometry pipeline by integrating the brain asymmetry factor into the model to help improving brain atrophy measurements.



Columbia University

• United States
• Higher Education
• 700 & Above Employee

• Research Associate

  • Jan 2016 - Dec 2016

  Project: Deposition of Amyloid-β plaques throughout the brain during asymptomatic as well as clinical stages of Alzheimer’s disease (AD) reveals a spatially heterogeneous patterns. Precise localisation and quantification of this imaging bio-marker or protein using Positron Emission Tomography (PET) imaging is therefore needed. As a research associate, I have developed and evaluated a technique that quantifies the extent of Amyloid-β pathology on a millimeter-by-millimeter scale in the brain with unprecedented precision using histopathology data from PET scans.



University of Iowa Health Care

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Research Scientist

  • Jan 2015 - Dec 2015

  Project: High-dose-rate gynaecologic brachytherapy (HGBT) for locally advanced cervical cancer is crucial for optimal outcomes. One of the challenges still faced when using 3D image guidance is applicator displacement that occurs when patients are transferred between the treatment room and the imaging room. As a research assistant, I have improved and validated a real-time applicator position monitoring system in HGBT Project: High-dose-rate gynaecologic brachytherapy (HGBT) for locally advanced cervical cancer is crucial for optimal outcomes. One of the challenges still faced when using 3D image guidance is applicator displacement that occurs when patients are transferred between the treatment room and the imaging room. As a research assistant, I have improved and validated a real-time applicator position monitoring system in HGBT



Aix-Marseille University

• France
• Higher Education
• 700 & Above Employee

• PhD

  • Dec 2011 - Nov 2014

  Title: Effect of drying conditions on spreading dynamics, on evaporation process and on pattern formation for drops of whole human blood Title: Effect of drying conditions on spreading dynamics, on evaporation process and on pattern formation for drops of whole human blood



GE HealthCare

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Research Engineer

  • Jan 2011 - Nov 2011

  Developed quantification tools in perfusion MRI for post therapeutic assessment in oncology Developed quantification tools in perfusion MRI for post therapeutic assessment in oncology